Bristol-Myers Squibb Pharmaceutical Research Institute
GPTKB entity
Properties (43)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:healthcare_organization
|
| gptkbp:collaboratesWith |
Academic institutions
Biotech_companies |
| gptkbp:employs |
Researchers
Scientists |
| gptkbp:focusesOn |
Drug discovery
|
| gptkbp:foundedIn |
2001
|
| gptkbp:hasAwards |
Innovation Awards
Research Excellence Awards |
| gptkbp:hasCollaborationsWith |
Public-private partnerships
International research initiatives Consortia |
| gptkbp:hasContent |
Industry conferences
Scientific meetings Annual research symposiums |
| gptkbp:hasFacilities |
Laboratories
Research centers Clinical trial sites |
| gptkbp:hasFunding |
Government grants
Private investments Corporate funding |
| gptkbp:hasLocalCuisine |
Phase IV
Phase II Phase III Phase I |
| gptkbp:hasPartnershipsWith |
Government agencies
Non-profit organizations |
| gptkbp:hasPublications |
Research papers
Scientific journals Clinical trial results |
| gptkbp:hasResearchFocus |
Immunology
Oncology Cardiovascular diseases Hematology Fibrosis |
| gptkbp:hasTheme |
Biologics
Combination therapies Drug formulations |
| https://www.w3.org/2000/01/rdf-schema#label |
Bristol-Myers Squibb Pharmaceutical Research Institute
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:parentOrganization |
gptkb:Bristol-Myers_Squibb_Company
|
| gptkbp:partOf |
gptkb:Bristol-Myers_Squibb_Company
|
| gptkbp:specializesIn |
Biopharmaceuticals
|